MCID: EXT010
MIFTS: 48

Extramedullary Plasmacytoma

Categories: Blood diseases, Cancer diseases

Aliases & Classifications for Extramedullary Plasmacytoma

MalaCards integrated aliases for Extramedullary Plasmacytoma:

Name: Extramedullary Plasmacytoma 12 15 74
Plasmacytoma, Extramedullary 12
Extraosseous Plasmacytoma 12

Classifications:



External Ids:

Disease Ontology 12 DOID:3720
NCIt 51 C4002
SNOMED-CT 69 10639003
ICD10 34 C90.2 C90.20
UMLS 74 C0278619

Summaries for Extramedullary Plasmacytoma

MalaCards based summary : Extramedullary Plasmacytoma, also known as plasmacytoma, extramedullary, is related to plasmacytoma and marginal zone b-cell lymphoma. An important gene associated with Extramedullary Plasmacytoma is B2M (Beta-2-Microglobulin), and among its related pathways/superpathways are Cytokine Signaling in Immune system and PI3K-Akt signaling pathway. The drugs Bortezomib and Cyclophosphamide have been mentioned in the context of this disorder. Affiliated tissues include bone, bone marrow and colon, and related phenotypes are digestive/alimentary and endocrine/exocrine gland

Related Diseases for Extramedullary Plasmacytoma

Diseases related to Extramedullary Plasmacytoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 151)
# Related Disease Score Top Affiliating Genes
1 plasmacytoma 32.4 B2M IGKC IL2 IL6
2 marginal zone b-cell lymphoma 30.2 BCL2 CCND1
3 solitary osseous plasmacytoma 30.1 B2M MYOM2
4 lymphoma, mucosa-associated lymphoid type 29.9 BCL2 CCND1 IGKC
5 myeloma, multiple 29.8 B2M CCND1 IL2 IL6 MYOM2
6 human immunodeficiency virus infectious disease 29.4 B2M IL2 IL6
7 acquired immunodeficiency syndrome 29.4 B2M IL2 IL6
8 leukemia, chronic lymphocytic 29.4 B2M BCL2 CCND1 IL2
9 extramedullary soft tissue plasmacytoma 10.4
10 lymphoma 10.3
11 amyloidosis 10.3
12 lymphoma, small cleaved-cell, diffuse 10.3 BCL2 CCND1
13 intravascular large b-cell lymphoma 10.2 B2M BCL2
14 hidradenocarcinoma 10.2 BCL2 CCND1
15 keratocystic odontogenic tumor 10.2 BCL2 CCND1
16 chondromyxoid fibroma 10.2 BCL2 CCND1
17 indolent myeloma 10.2 B2M MYOM2
18 syphilis 10.2 B2M BCL2
19 waldenstroem's macroglobulinemia 10.2 B2M MYOM2
20 amyloid tumor 10.2 B2M MYOM2
21 non-secretory myeloma 10.2 B2M MYOM2
22 primary central nervous system lymphoma 10.2 BCL2 IL2
23 leukemia 10.2
24 squamous cell carcinoma 10.2
25 adenocarcinoma 10.2
26 vernal conjunctivitis 10.1 B2M IL2
27 progressive multifocal leukoencephalopathy 10.1 BCL2 IL2
28 b-cell expansion with nfkb and t-cell anergy 10.1 B2M IL2
29 hypersensitivity reaction type iv disease 10.1 IL2 MYOM2
30 ocular cancer 10.1 CCND1 IL2
31 intussusception 10.1
32 pancreatic cancer 10.1
33 b-cell lymphomas 10.1
34 ulcerative colitis 10.1
35 colitis 10.1
36 sarcoma 10.1
37 obstructive jaundice 10.1
38 thyroiditis 10.1
39 follicular lymphoma 10.0 BCL2 CCND1
40 ovarian serous cystadenocarcinoma 10.0 B2M BCL2
41 mycosis fungoides 10.0
42 cardiac tamponade 10.0
43 cholestasis 10.0
44 extrahepatic cholestasis 10.0
45 plasmablastic lymphoma 10.0
46 pyelitis 10.0 B2M IL6
47 post-transplant lymphoproliferative disease 10.0 B2M IL6
48 hemorrhagic fever 10.0 B2M IL6
49 human herpesvirus 8 10.0 BCL2 IL6
50 meningoencephalitis 10.0 B2M IL6

Graphical network of the top 20 diseases related to Extramedullary Plasmacytoma:



Diseases related to Extramedullary Plasmacytoma

Symptoms & Phenotypes for Extramedullary Plasmacytoma

MGI Mouse Phenotypes related to Extramedullary Plasmacytoma:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 digestive/alimentary MP:0005381 9.65 B2M BCL2 CCND1 IL2 IL6
2 endocrine/exocrine gland MP:0005379 9.55 B2M BCL2 CCND1 IL2 IL6
3 neoplasm MP:0002006 9.35 B2M BCL2 CCND1 IL2 IL6
4 reproductive system MP:0005389 9.02 B2M BCL2 CCND1 IL2 IL6

Drugs & Therapeutics for Extramedullary Plasmacytoma

Drugs for Extramedullary Plasmacytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 233)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Bortezomib Approved, Investigational Phase 3,Phase 2,Phase 1 179324-69-7 387447 93860
2
Cyclophosphamide Approved, Investigational Phase 3,Phase 2,Phase 1 6055-19-2, 50-18-0 2907
3
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
4
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 1177-87-3
5
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 50-02-2 5743
6
Ketamine Approved, Vet_approved Phase 3 6740-88-1 3821
7
Prednisone Approved, Vet_approved Phase 3,Phase 2,Phase 1 53-03-2 5865
8
Aspirin Approved, Vet_approved Phase 3 50-78-2 2244
9
Melphalan Approved Phase 3,Phase 2 148-82-3 460612 4053
10
Lenalidomide Approved Phase 3,Phase 2,Phase 1 191732-72-6 216326
11
Darbepoetin alfa Approved, Investigational Phase 3,Phase 2 11096-26-7, 209810-58-2
12
Iron Approved, Experimental Phase 3,Phase 1,Phase 2 7439-89-6, 15438-31-0 23925 27284
13
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
14
Dalteparin Approved Phase 3 9005-49-6
15
Heparin Approved, Investigational Phase 3 9005-49-6 772 46507594
16
Ondansetron Approved Phase 3 99614-02-5 4595
17
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 1,Phase 2,Not Applicable 22916-47-8 4189
18
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
19
Caspofungin Approved Phase 3,Phase 2 179463-17-3, 162808-62-0 2826718 468682
20
Guaifenesin Approved, Investigational, Vet_approved Phase 3,Not Applicable 93-14-1 3516
21
Dextromethorphan Approved Phase 3 125-71-3 5362449 5360696
22
Morphine Approved, Investigational Phase 3,Not Applicable 57-27-2 5288826
23
Ginseng Approved, Investigational, Nutraceutical Phase 3 50647-08-0
24
St. John's Wort Approved, Investigational, Nutraceutical Phase 3 84082-80-4
25
Doxil Approved June 1999 Phase 3,Phase 2,Phase 1 31703
26 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
27 Peripheral Nervous System Agents Phase 3,Phase 2,Phase 1,Not Applicable
28 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1,Not Applicable
29 Anti-Inflammatory Agents Phase 3,Phase 2,Phase 1
30 Antineoplastic Agents, Alkylating Phase 3,Phase 2,Phase 1
31 HIV Protease Inhibitors Phase 3,Phase 2,Phase 1
32 Hormones Phase 3,Phase 2,Phase 1
33
protease inhibitors Phase 3,Phase 2,Phase 1
34 Autonomic Agents Phase 3,Phase 2,Phase 1
35 BB 1101 Phase 3,Phase 2,Phase 1
36 Immunosuppressive Agents Phase 3,Phase 2,Phase 1,Not Applicable
37 Antineoplastic Agents, Hormonal Phase 3,Phase 2,Phase 1
38 Hormone Antagonists Phase 3,Phase 2,Phase 1
39 Immunologic Factors Phase 3,Phase 2,Phase 1,Not Applicable
40 Topoisomerase Inhibitors Phase 3,Phase 2,Phase 1,Not Applicable
41 Alkylating Agents Phase 3,Phase 2,Phase 1
42 Antibiotics, Antitubercular Phase 3,Phase 2,Phase 1,Not Applicable
43 Antiemetics Phase 3,Phase 2,Phase 1
44 Antirheumatic Agents Phase 3,Phase 2,Phase 1,Not Applicable
45 Gastrointestinal Agents Phase 3,Phase 2,Phase 1
46 Proteasome Inhibitors Phase 3,Phase 1
47 glucocorticoids Phase 3,Phase 2,Phase 1
48 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 3,Phase 2,Phase 1
49 Excitatory Amino Acids Phase 3
50 Anesthetics, General Phase 3

Interventional clinical trials:

(show top 50) (show all 75)
# Name Status NCT ID Phase Drugs
1 CDD Plus Bortezomib or CDDin Relapsed or Refractory Multiple Myeloma With Extramedullary Plasmacytoma Unknown status NCT02336386 Phase 3 CDD;CDD Plus Bortezomib
2 Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Unknown status NCT01316744 Phase 3 ketamine hydrochloride
3 A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older. Completed NCT00405756 Phase 3 Lenalidomide: Double-blind Induction;Melphalan;Prednisone;Aspirin;Placebo;Lenalidomide: Double-blind Maintenance;Lenalidomide: Open-label
4 A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma Completed NCT00424047 Phase 3 CC-5013 plus dexamethasone;Dexamethasone plus Placebo
5 A Multicenter, Single-Arm, Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma Completed NCT00478777 Phase 3 Lenalidomide;dexamethasone
6 A Companion Study for Studies THAL-MM-003, CC-5013-MM-009, and CC-5013-MM-010 for Subjects With Multiple Myeloma Completed NCT00622336 Phase 3 Lenalidomide
7 Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer Completed NCT00661999 Phase 3 sodium ferric gluconate complex in sucrose
8 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
9 American Ginseng in Treating Patients With Fatigue Caused by Cancer Completed NCT00719563 Phase 3 American ginseng
10 Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain Completed NCT00666211 Phase 3
11 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
12 Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer Completed NCT00070382 Phase 3 darbepoetin alfa;epoetin alfa
13 St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Completed NCT00005805 Phase 3
14 Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Completed NCT00006083 Phase 3 Fragmin
15 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Completed NCT00006348 Phase 3 ondansetron
16 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
17 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
18 Treatment for Chronic Pain in Patients With Advanced Cancer Completed NCT00003687 Phase 3 dextromethorphan hydrobromide;morphine sulfate
19 Beta Alethine in Treating Patients With Myeloma Unknown status NCT00006466 Phase 1, Phase 2 beta alethine
20 Study of Bortezomib and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma Completed NCT01478048 Phase 2 Bortezomib;Dexamethasone;Dexamethasone;Dexamethasone;Dexamethasone
21 Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer Completed NCT00489203 Phase 2 beclomethasone dipropionate;placebo;tacrolimus;methotrexate
22 Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy Completed NCT00416624 Phase 2 darbepoetin alfa;epoetin alfa
23 SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant Completed NCT00002657 Phase 2 cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;methotrexate;prednisone;vincristine sulfate
24 Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer Completed NCT00823524 Phase 1, Phase 2
25 Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer Completed NCT00255749 Phase 2
26 Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer Completed NCT00002504 Phase 2
27 Busulfan, Fludarabine, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Hematologic Cancer Completed NCT00245037 Phase 1, Phase 2 busulfan;cyclosporine;fludarabine phosphate;mycophenolate mofetil;Granulocyte colony-stimulating factor (G-CSF);Phenytoin;Methotrexate
28 Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer Completed NCT00003406 Phase 1, Phase 2 carboplatin;docetaxel;ifosfamide
29 Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant Completed NCT00110045 Phase 2 caspofungin acetate
30 Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Completed NCT00010283 Phase 1, Phase 2 beclomethasone dipropionate
31 Non-Ablative Allo HSCT For Hematologic Malignancies or SAA Completed NCT00006379 Phase 2 cyclophosphamide;fludarabine phosphate
32 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00005804 Phase 2 cyclophosphamide
33 Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer Completed NCT00006225 Phase 1, Phase 2
34 Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation Completed NCT00005606 Phase 2
35 Pomalidomide, Ixazomib Citrate, and Dexamethasone in Treating Patients With Previously Treated Multiple Myeloma or Plasma Cell Leukemia Recruiting NCT02547662 Phase 2 Dexamethasone;Ixazomib Citrate;Pomalidomide
36 Short Course Daratumumab in Patients With Multiple Myeloma Recruiting NCT03490344 Phase 2 Daratumumab;Lenalidomide
37 Autologous Stem Cell Transplant Followed By Maintenance Therapy in Treating Elderly Patients With Multiple Myeloma Active, not recruiting NCT01849783 Phase 2 dexamethasone;cisplatin;doxorubicin;cyclophosphamide;etoposide;bortezomib;thalidomide;melphalan
38 S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma Terminated NCT00109889 Phase 2
39 Velcade Combined With High-Dose Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Terminated NCT00337506 Phase 2 Dexamethasone;velcade
40 Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies Withdrawn NCT01101412 Phase 1, Phase 2 Edetate Calcium Disodium;Ethanol;Trimethoprim-sulfamethoxazole
41 Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer Unknown status NCT00004036 Phase 1 amifostine trihydrate;carboplatin;cyclophosphamide
42 Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy Completed NCT00890747 Phase 1 sunitinib malate
43 Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction Completed NCT00025415 Phase 1 imatinib mesylate
44 Japanese Study of BMS-901608 (Elotuzumab) in Combination With Lenalidomide and Low Dose Dexamethasone Completed NCT01241292 Phase 1
45 PS-341 in Treating Patients With Advanced Cancer Completed NCT00006362 Phase 1 bortezomib
46 Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy Completed NCT00005634 Phase 1 vorinostat
47 Decitabine in Treating Patients With Melanoma or Other Advanced Cancer Completed NCT00002980 Phase 1 decitabine
48 Interleukin-12 Followed by Interferon Alfa in Treating Patients With Advanced Cancer Completed NCT00003451 Phase 1
49 Combination Chemotherapy in Treating Patients With Advanced Cancer Completed NCT00003331 Phase 1 fluorouracil;leucovorin calcium;topotecan hydrochloride
50 Monoclonal Antibody Therapy in Treating Patients With Advanced Cancer Completed NCT00003082 Phase 1

Search NIH Clinical Center for Extramedullary Plasmacytoma

Genetic Tests for Extramedullary Plasmacytoma

Anatomical Context for Extramedullary Plasmacytoma

MalaCards organs/tissues related to Extramedullary Plasmacytoma:

42
Bone, Bone Marrow, Colon, Breast, Thyroid, Liver, Pancreas

Publications for Extramedullary Plasmacytoma

Articles related to Extramedullary Plasmacytoma:

(show top 50) (show all 570)
# Title Authors Year
1
Endobronchial Obstruction by a Solitary Extramedullary Plasmacytoma With Light-chain Amyloidosis. ( 30908398 )
2019
2
Sudden and unexpected death due to intracranial sellar extramedullary plasmacytoma. ( 30503990 )
2019
3
Solitary extramedullary plasmacytoma of palatine tonsil - a rare albeit possible entity. ( 30608059 )
2019
4
Extramedullary plasmacytoma of the right main bronchus. ( 30682355 )
2019
5
Extramedullary plasmacytoma of tonsil: an unusual site. ( 30706889 )
2019
6
Refractory ascites as a presenting feature of extramedullary plasmacytoma in an end-stage renal disease patient with HIV infection. ( 30838169 )
2019
7
Relapsed multiple myeloma manifesting as extramedullary plasmacytoma of the breast: Imaging findings. ( 30891107 )
2019
8
Extramedullary plasmacytoma. ( 29496243 )
2018
9
Treatment of relapsed multiple myeloma complicated by cardiac extramedullary plasmacytoma with D-PACE chemotherapy. ( 29523615 )
2018
10
Atypical Presentation of Extramedullary Plasmacytoma. ( 29559881 )
2018
11
Extramedullary plasmacytoma of the trachea: A case report and review of the literature. ( 29504982 )
2018
12
Gastrointestinal manifestations of extramedullary plasmacytoma: a narrative review and illustrative case reports. ( 29692194 )
2018
13
Extramedullary plasmacytoma of the testis: A case report. ( 29204364 )
2018
14
Collet-Sicard Syndrome Attributable to Extramedullary Plasmacytoma of the Jugular Foramen. ( 29191538 )
2018
15
Pattern of care and impact of prognostic factors on the outcome of head and neck extramedullary plasmacytoma: a systematic review and individual patient data analysis of 315 cases. ( 29224044 )
2018
16
Primary extramedullary plasmacytoma of the sigmoid colon with perforation: a case report. ( 29619633 )
2018
17
Extramedullary plasmacytoma: rare neoplasm of parotid gland. ( 29301803 )
2018
18
Diagnosis of solitary extramedullary plasmacytoma located in the nasopharynx in a patient with acquired angioedema. ( 30618535 )
2018
19
A Case of Multiple Myeloma Associated with Extramedullary Plasmacytoma of the Gallbladder Manifesting as Acute Cholecystitis. ( 30050743 )
2018
20
Solitary extramedullary plasmacytoma of the rectum complicating ulcerative colitis. ( 30238285 )
2018
21
Five cases of orbital extramedullary plasmacytoma: diagnosis and management of an aggressive malignancy. ( 29985709 )
2018
22
Extramedullary Plasmacytoma of the Pancreas Complicated with Left-Sided Portal Hypertension-a Case Report and Literature Review. ( 30033507 )
2018
23
Extramedullary plasmacytoma of the larynx: Literature review and report of a case who subsequently developed acute myeloid leukemia. ( 30127889 )
2018
24
Concomitant Extramedullary Plasmacytoma in the Oropharynx and Hypopharyngeal Squamous Cell Carcinoma. ( 30155331 )
2018
25
Pancreatic Extramedullary Plasmacytoma Presenting as a Pancreatic Mass. ( 30262989 )
2018
26
Solitary Extramedullary Plasmacytoma Mimicking Acute Subdural Hematoma. ( 30268553 )
2018
27
Primary solitary extramedullary plasmacytoma progressing to multiple bone plasmacytomas: a rare condition with therapeutic dilemmas. ( 30335051 )
2018
28
Retroperitoneal extramedullary plasmacytoma: A case report and review of the literature. ( 30431616 )
2018
29
Secondary extramedullary plasmacytoma of sigmoid colon in a patient with multiple myeloma: a case report. ( 30583721 )
2018
30
Uterine Extramedullary Plasmacytoma as a Primary Manifestation of Multiple Myeloma. ( 28834996 )
2017
31
Extramedullary Plasmacytoma Arising From the Anterior Mediastinum. ( 28431708 )
2017
32
Clinical findings in 25 patients with sinonasal or nasopharyngeal extramedullary plasmacytoma in a four-decade single-centre series. ( 28537101 )
2017
33
Management of extramedullary plasmacytoma: Role of radiotherapy and prognostic factor analysis in 55 patients. ( 29142463 )
2017
34
Extramedullary plasmacytoma occuring in ileocecum: A case report and literature review. ( 29390503 )
2017
35
Extramedullary plasmacytoma of the testicle. ( 29205163 )
2017
36
Rare Presentation of Primary Extramedullary Plasmacytoma as Lip Lesion. ( 28409043 )
2017
37
Strategy for the treatment and follow-up of sinonasal solitary extramedullary plasmacytoma: a case series. ( 28793931 )
2017
38
Extramedullary plasmacytoma of the lateral rectus muscle. ( 28267386 )
2017
39
Primary extramedullary plasmacytoma mimicking oral lichen planus. ( 28944756 )
2017
40
An extramedullary plasmacytoma in the kidney of a 14-year-old girl: Case report and review of the literature. ( 28178171 )
2017
41
Extramedullary plasmacytoma mimicking pancreatic cancer: A case report and literature review. ( 28663530 )
2017
42
Marginal zone B-cell lymphoma mimicking extramedullary plasmacytoma and the clinical outcome after treatment. ( 28507591 )
2017
43
Oral extramedullary plasmacytoma in a HIV positive patient. ( 27894848 )
2017
44
Multiple Extramedullary Plasmacytoma in a Setting of Complete Bone Marrow Remission: Food for Thought. ( 29340123 )
2017
45
Solitary Extramedullary Plasmacytoma of the Cricoid Cartilage-Case Report. ( 29230383 )
2017
46
Extramedullary plasmacytoma in the airway of an HIV-positive child. ( 28834349 )
2017
47
Extramedullary Plasmacytoma of the Oral Cavity in a Young Man: a Case Report. ( 27284562 )
2016
48
Atrophoderma of Pasini and Pierini associated with extramedullary plasmacytoma. ( 27443586 )
2016
49
Multiple primary cutaneous plasmacytoma a decade after a nasal solitary extramedullary plasmacytoma: a puzzling case. ( 27980740 )
2016
50
Apparent diffusion coefficient map of a case of extramedullary plasmacytoma. ( 27200157 )
2016

Variations for Extramedullary Plasmacytoma

Expression for Extramedullary Plasmacytoma

Search GEO for disease gene expression data for Extramedullary Plasmacytoma.

Pathways for Extramedullary Plasmacytoma

Pathways related to Extramedullary Plasmacytoma according to GeneCards Suite gene sharing:

(show all 27)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
12.96 B2M BCL2 CCND1 IL2 IL6
2
Show member pathways
12.66 BCL2 CCND1 IL2 IL6
3
Show member pathways
12.64 B2M BCL2 CCND1 IL6
4
Show member pathways
12.52 B2M CCND1 IL2 IL6
5 12.46 BCL2 CCND1 IL2 IL6
6
Show member pathways
12.31 BCL2 IL2 IL6
7
Show member pathways
12.3 BCL2 IL2 IL6
8 12.08 CCND1 IL2 IL6
9
Show member pathways
11.92 BCL2 CCND1 IL2 IL6
10
Show member pathways
11.8 BCL2 IL2 IL6
11 11.66 CCND1 IL2 IL6
12 11.6 BCL2 CCND1 IL6
13 11.5 BCL2 CCND1 IL6
14
Show member pathways
11.46 BCL2 IL2
15 11.45 CCND1 IL2
16
Show member pathways
11.41 B2M IL2
17 11.4 BCL2 CCND1
18 11.31 CCND1 IL6
19 11.13 CCND1 IL6
20
Show member pathways
11.13 CCND1 IL2 IL6
21 11.11 CCND1 IL6
22 11.02 IL2 IL6
23 10.95 BCL2 IL2
24 10.92 BCL2 IL2 IL6
25 10.87 BCL2 CCND1 IL6
26 10.77 BCL2 IL6
27 10.63 BCL2 CCND1 IL2 IL6

GO Terms for Extramedullary Plasmacytoma

Biological processes related to Extramedullary Plasmacytoma according to GeneCards Suite gene sharing:

(show all 16)
# Name GO ID Score Top Affiliating Genes
1 response to drug GO:0042493 9.71 B2M BCL2 CCND1
2 positive regulation of cell proliferation GO:0008284 9.62 BCL2 CCND1 IL2 IL6
3 positive regulation of T cell proliferation GO:0042102 9.56 IL2 IL6
4 immune response GO:0006955 9.56 B2M IGKC IL2 IL6
5 humoral immune response GO:0006959 9.55 BCL2 IL6
6 cellular response to organic substance GO:0071310 9.52 BCL2 CCND1
7 retina homeostasis GO:0001895 9.51 B2M IGKC
8 positive regulation of B cell proliferation GO:0030890 9.49 BCL2 IL2
9 T cell differentiation GO:0030217 9.48 BCL2 IL2
10 extrinsic apoptotic signaling pathway in absence of ligand GO:0097192 9.46 BCL2 IL2
11 response to steroid hormone GO:0048545 9.43 BCL2 CCND1
12 T cell differentiation in thymus GO:0033077 9.4 B2M BCL2
13 response to iron ion GO:0010039 9.37 BCL2 CCND1
14 positive regulation of immunoglobulin secretion GO:0051024 9.16 IL2 IL6
15 response to glucocorticoid GO:0051384 9.13 BCL2 CCND1 IL6
16 cytokine-mediated signaling pathway GO:0019221 8.92 BCL2 CCND1 IL2 IL6

Sources for Extramedullary Plasmacytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....